Impact Life Fund

About Impact Life Fund

The Impact Life Fund invests in Life Science Technologies which increase and sustain life, Engineering innovations that create a more sustainable environment and Software and Data Science that will democratize skills and knowledge. It uses a proprietary methodology for measuring “life impact” and in particular “Equivalent Lives Impacted” which is calculated throughout both the investment period as well as a generational timeframe. No fees are taken until exit, and only then if the investment is at least 125% of the original amount.

Summary


Fund Manager:	Boundary Capital
Tax Efficiency:	EIS
Sector Focus:	Impact investments across Life Science Tech, Engineering, Software and Data Science
Stage Focus:	Early-stage & growth-stage
Target Portfolio Size:	5-9
Minimum Subscription:	£20,000
Closing Date:	Evergreen
Website:	Learn more about the Impact Life Fund

Boundary Capital

Boundary Capital is an impact investment fund that invests in high growth private technology companies. Its expertise spans life sciences, AI and engineering, and it is an HMRC approved knowledge intensive fund.

How does SyndicateRoom''s Access EIS Fund compare?

By comparison, SyndicateRoom''s Access EIS fund builds investors a large portfolio of 50+ companies across all sectors, co-investing with experienced angel investors who have an average IRR of 42%. Our model is based on our proprietary analysis of the UK startup market, which showed that on average, the market grows by 28% each year. With large portfolios, and a large network of angels providing access to the best deals, earlier, we aim to replicate that annual growth for our investors while mitigating risk. This data-driven approach aims to work around the limitations of a single fund manager attempting to pick winners.

Our minimum investment is £5,000.


Fund Manager:	SyndicateRoom
Tax Efficiency:	EIS
Sector Focus:	Sector Agnostic
Stage Focus:	Early-stage
Target Portfolio Size:	50+ companies
Minimum Subscription:	£5,000
Closing Date:	Evergreen
Website:	Learn more about the Access EIS Fund

Please note: SyndicateRoom is not affiliated with the Impact Life Fund. This page is for informational purposes only, and is the result of research conducted by SyndicateRoom. Whilst every effort has been taken to ensure accuracy at the time of publication this cannot be guaranteed and information is liable to change. Information displayed is neither a recommendation to invest or not, nor advice. With investments, your capital is at risk. SyndicateRoom is not responsible for the content of any external websites linked to from this page.

Are you the fund manager? Email tom@syndicateroom.com with any comments or amends.

Risk warning: Please click here to read the full risk warning.

Investing in early-stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. Tax relief depends on an individual’s circumstances and may change in the future. In addition, the availability of tax relief depends on the company invested in maintaining its qualifying status. Past performance is not a reliable indicator of future performance. You should not rely on any past performance as a guarantee of future investment performance.

This page has been approved as a financial promotion by Syndicate Room Ltd, which is authorised and regulated by the Financial Conduct Authority (No. 613021).

We use cookies to improve our service. By continuing to use this site you are agreeing to their use. Find out more.